Journal of Disability and Oral Health
- Cover Date:
- December 2010
- Print ISSN:
- 1470-8558
- Vol:
- 11
- Issue:
- 4
Bisphosphonates, oral implants and osteonecrosis of the jaw: a review and guidelines
Abstract Bisphosphonate drug groups are widely used in the treatment of bone disorders. They may be taken orally or intravenously. One complication of their use is a relatively new clinical condition known as osteonecrosis of the jaw (ONJ). This condition is reported to exclusively affect the mandible and maxilla to different degrees. Dental professionals will increasingly manage patients who are at risk of developing ONJ as the use of these drug groups is rising. Furthermore, knowledge among many healthcare professionals about bisphosphonates and their side effects is limited. Therefore, ONJ presents a challenge to the professional and requires a good understanding of how to manage the clinical situation. The purpose of this paper is to review the bisphosphonate drug groups, their effects on bone activity and how they may affect treatment outcome with oral implants. Guidelines for management of patients who are at risk of developing ONJ are also addressed.
Key words: Osteonecrosis of the jaw, bisphosphonates, oral implant, guidelines
- Article Price
- £15.00
- Institution Article Price
- £
- Page Start
- 155
- Page End
- 162
- Authors
- Abdulhadi Warreth, Najia Ibieyou, Denise MacCarthy
Articles from this issue
- Title
- Pg. Start
- Pg. End
- Oral health status and dental treatment needs in institutionalised versus non-institutionalised psychiatric patients
- 163
- 170
- Oral health and children with an intellectual disability: a focus group study of parent issues and perceptions.
- 171
- 177
- ‘Emily goes to the dentist’ - oral care for individuals with Down syndrome in the Netherlands
- 180
- 182
- Oral radiological findings in a population of athletes at the III Para-Pan American Games, Rio de Janeiro, Brazil
- 187
- 191